| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |